首页 | 本学科首页   官方微博 | 高级检索  
     

两种伐昔洛韦抑制疗法方案预防生殖器疱疹复发作用比较
引用本文:刘恩让,张书岭,王福喜,谢倩,刘姝丽. 两种伐昔洛韦抑制疗法方案预防生殖器疱疹复发作用比较[J]. 中国医院用药评价与分析, 2007, 7(4): 304-305
作者姓名:刘恩让  张书岭  王福喜  谢倩  刘姝丽
作者单位:深圳市第二人民医院皮肤科,深圳市,518035
摘    要:目的:比较两种伐昔洛韦抑制疗法方案预防生殖器疱疹复发的临床效果。方法:将87例频发性生殖器疱疹患者(>3次/半年)随机分成2组,Ⅰ组42例患者口服万乃洛韦,300mg每日1次,。连续服用6个月。Ⅱ组45例患者口服万乃洛韦300mg,隔日1次,连续服用6个月。分别对用药前及用药6个月后的复发情况进行观察。结果:两种方案治疗后平均复发次数明显减少,但两组间平均复发次数差异无显著性(P>0.05)。结论:两种治疗方案对预防频发性生殖器疱疹复发疗效相同。

关 键 词:生殖器疱疹  复发  伐昔洛韦  万乃洛韦  临床疗效
文章编号:1672-2124(2007)04-0304-02
修稿时间:2007-03-13

Two Valaciclovir Suppressive Therapies in Preventing Genital Herpes Recurrence
LIU Enrang,ZHANG Shuling,WANG Fuxi,XIE Qian,LIU Shuli. Two Valaciclovir Suppressive Therapies in Preventing Genital Herpes Recurrence[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2007, 7(4): 304-305
Authors:LIU Enrang  ZHANG Shuling  WANG Fuxi  XIE Qian  LIU Shuli
Abstract:OBJECTIVE: To compare the clinical efficacies of two Valaciclovir suppressive therapies in the prevention of genital herpes recurrence.METHODS: A total of 87 patients with recurrent genital herpes were randomly divided into two groups: group I(n=42) was assigned to receive oral Valaciclovir(at a dose of 300mg) q.d for 6 consecutive months,and group II(n=45) to receive Valaciclovir(at a dose of 300mg) every other day for 6 consecutive months.The recurrences in two groups were compared before medication and at 6 months after medication,respectively.RESULTS: The average number of times of recurrences of genital herpes were significantly decreased in both groups,but there was no significant difference between two groups(P>0.05).CONCLUSION: Two Valaciclovir suppressive therapies showed similar efficacy in the prevention of recurrent genital herpes.
Keywords:Genital herpes  Recurrence  Valaciclovir  Valaciclovir  Clinical efficacy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号